Agarwal Arjun sold ORKA
June 12, 2026 · Form 4 insider transaction
Agarwal Arjun sold 4,340 shares of Oruka Therapeutics, Inc. at $69.85 per share, a transaction worth $303.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,340
Price
$69.85
Total value
$303.2K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 12, 2026
Filing dateJune 15, 2026
Shares owned after20,554
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.07 to $70.06, inclusive.